Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,693
Closed -$784K 2191
2021
Q3
$784K Buy
12,693
+8,402
+196% +$553K ﹤0.01% 1667
2021
Q2
$365K Buy
4,291
+1,431
+50% +$131K ﹤0.01% 1995
2021
Q1
$226K Sell
2,860
-3,749
-57% -$243K ﹤0.01% 2077
2020
Q4
$385K Sell
6,609
-13,228
-67% -$623K ﹤0.01% 1875
2020
Q3
$672K Sell
19,837
-32,784
-62% -$1.24M ﹤0.01% 1608
2020
Q2
$2.43M Sell
52,621
-57,168
-52% -$1.59M ﹤0.01% 1070
2020
Q1
$1.74M Buy
109,789
+3,500
+3% +$83.3K ﹤0.01% 1124
2019
Q4
$2.91M Buy
106,289
+16,841
+19% +$450K ﹤0.01% 1122
2019
Q3
$2.63M Buy
+89,448
New +$2.66M ﹤0.01% 1183

Other funds holding AFMD

Cliff Asness's AFMD Position: Q4 2021 in Review

Cliff Asness sold out of Affimed (AFMD) in Q4 2021, closing a stake of 12,693 shares — an estimated $784K sold.

Cliff Asness first reported a position in AFMD in Q3 2019 and held it in 9 quarters. The position peaked at $2.91M in Q4 2019. 123 funds tracked by Wall St. Rank hold AFMD as of Q4 2021.

  • Cliff Asness reported no remaining Affimed position as of Q4 2021 after selling out during the quarter.
  • Cliff Asness sold 12,693 Affimed shares in Q4 2021, an estimated $784K.
  • Cliff Asness first reported a position in Affimed in Q3 2019 and held it in 9 quarters.
  • Cliff Asness's Affimed position peaked at $2.91M in Q4 2019.
  • 123 funds tracked by Wall St. Rank held Affimed as of Q4 2021.

Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.